Skip to main content
Premium Trial:

Request an Annual Quote

Dharmacon and UMMS Join for RNAi Obesity and Diabetes Studies

NEW YORK, Jan. 8 (GenomeWeb News) - Dharmacon and the University of Massachusetts Medical School said today they will collaborate in studies of obesity and diabetes using RNA interference.

 

Dharmacon, based in Lafayette, Colo., will provide UMMS researchers, directed by Michael Czech, with siRNA reagents for the studies. The scientists plan to assess several thousand gene targets over a three-year period.

 

In return, Dharmacon will obtain access to the study data to assess the effectiveness of its siRNA technologies.

 

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.